[{"AccruedLiabilitiesCurrent_0_Q2_USD":1037253.0,"NetIncomeLoss_2_Q2_USD":-1981637.0,"OperatingIncomeLoss_1_Q2_USD":-337582.0,"OperatingIncomeLoss_2_Q2_USD":-1527703.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2686854.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-453934.0,"PaymentsForProceedsFromDepositOnLoan_2_Q2_USD":300000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":237197.0,"PaymentsToInvestInDecommissioningFund_2_Q2_USD":207000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockSharesIssued_0_Q2_shares":null,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PreferredStockValue_0_Q2_USD":null,"PrepaidExpenseCurrent_0_Q2_USD":835471.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":206750001.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":2000000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":6000.0,"ProfitLoss_1_Q2_USD":-3024436.0,"PublicUtilitiesApprovedReturnOnEquityPercentage_2_Q2_pure":0.2,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1984165.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0_Q2_USD":11.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.18,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0106,"SharesIssuedPricePerShare_0_Q2_USD":10.0,"StockholdersEquity_0_Q2_USD":5000006.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":3024440.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":187414590.0,"UnrealizedGainLossOnDerivatives_1_Q2_USD":-2690000.0,"NetIncomeLoss_1_Q2_USD":-3024436.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1278271.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-207000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":208218804.0,"AdditionalPaidInCapital_0_Q2_USD":6983457.0,"Assets_0_Q2_USD":207938418.0,"AssetsCurrent_0_Q2_USD":932852.0,"AssetsHeldInTrust_0_Q2_USD":207005566.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":207005566.0,"Cash_0_Q2_USD":97381.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":97381.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-59467.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockValue_0_Q2_USD":196.0,"DebtConversionConvertedInstrumentRate_2_Q2_pure":0.2,"DebtInstrumentRedemptionPricePercentage_2_Q2_pure":0.02,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q2_USD":null,"DueToRelatedPartiesCurrent_0_Q2_USD":null,"UnrealizedGainLossOnDerivatives_2_Q2_USD":813000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2_Q2_pure":0.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3_2_Q2_USD":9000000.0,"GainLossOnSaleOfDerivatives_2_Q2_USD":-1272500.0,"GainLossOnSaleOfDerivatives_1_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":337582.0,"GeneralAndAdministrativeExpense_2_Q2_USD":1527703.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1034725.0,"IncreaseDecreaseInPrepaidExpensesOther_2_Q2_USD":835471.0,"InterestIncomeSecuritiesOtherUSGovernment_1_Q2_USD":3146.0,"InterestIncomeSecuritiesOtherUSGovernment_2_Q2_USD":5566.0,"InvestmentIncomeInterest_2_Q2_USD":5566.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":1272500.0,"Liabilities_0_Q2_USD":15523822.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":207938418.0,"LiabilitiesCurrent_0_Q2_USD":1155822.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-813000.0,"WarrantsAndRightsOutstanding_0_Q2_USD":14368000.0,"Ticker":"GRNA","CIK":"1822691","name":"ENVIRONMENTAL IMPACT ACQUISITION CORP","OfficialName":"GreenLight Biosciences Holdings PBC Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1030624353.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210813"}]